Repeat expansion disorder

Bio Roundup: Sarepta's Stumble, Opioid Suits, Shkreli's Legacy & More

Bio Roundup: Sarepta's Stumble, Opioid Suits, Shkreli's Legacy & More

13 hours ago   |   Xconomy

Biotech news tends to slow down in August but the past seven days have been busy for regulatory decisions. Three drugs and two devices won FDA nods. Not all companies were as...
Read more ...

Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails

Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails

1 day ago   |   Xconomy

Retrophin, the drug developer founded by jailed former biotech executive Martin Shkreli, has failed its first big test. The San Diego-based company's experimental drug...
Read more ...

Avidity Biosciences Adds Drug Development Veterans Edward Kaye and Noreen Henig to Board of Directors

1 day ago   |   San Diego Biotechnology

LA JOLLA, Calif., Aug. 22, 2019 /PRNewswire/ - Avidity Biosciences, a biotechnology company pioneering Antibody-Oligonucleotide Conjugates focused in rare muscle disorders and...
Read more ...

Environmental DNA proves the expansion of invasive crayfish habitats

2 days ago   |   ScienceDaily

Environmental DNA has successfully proven the presence of invasive crayfish in almost all the small streams around Lake Akan in Japan, suggesting that eDNA analysis is an...
Read more ...

When Size Matters: Using SMRT Sequencing to Help Patients With Repeat Expansion Disorders 

When Size Matters: Using SMRT Sequencing to Help Patients With Repeat Expansion Disorders 

4 days ago   |   Pacific Biosciences

Patients with myotonic dystrophy type 1 want to know their size - the size of the expansion of repeats of the unstable CTG sequences that cause the progressive deterioration of...
Read more ...

An enhanced genetic model of colorectal cancer progression history

6 days ago   |   Genome Biology

The classical genetic model of colorectal cancer presents APC mutations as the earliest genomic alterations, followed by KRAS and TP53 mutations. However, the timing and...
Read more ...

Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs

Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs

6 days ago   |   Xconomy

The dog days of summer are here and IPO activity has slowed, but that hasn't stopped some biotech companies from securing a place in the line leading to Wall Street. Late...
Read more ...

AbbVie's Successor to Humira Wins FDA OK for Rheumatoid Arthritis

AbbVie's Successor to Humira Wins FDA OK for Rheumatoid Arthritis

7 days ago   |   Xconomy

An anti-inflammatory drug that AbbVie has been developing as a successor to adalimumab , the world's top-selling drug, won the regulatory OK Friday as a treatment for...
Read more ...

AntiHIV-Pred: Web-resource for in silico prediction of anti-HIV/AIDS activity

7 days ago   |   Oxford Journals

AbstractMotivationIdentification of new molecules promising for treatment of HIV-infection and HIV-associated disorders remains an important task in order to provide safer and...
Read more ...

RIP Kary Mullis, Father of PCR

RIP Kary Mullis, Father of PCR

8 days ago   |   DNA Science

When the name Kary Mullis popped up in my news feed on Monday, I was excited to read what I thought would be an update on the renegade inventor I'd met years ago at a small...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Why Amazon's Ascent Spells Bad News for Mall Food Courts

Why Amazon's Ascent Spells Bad News for Mall Food Courts

The increasing popularity of Amazon's annual Prime Day, Cyber Monday, and other online shopping-themed occasions is one of many indicators more Americans are relying on mobile... Read more ...

VMware: “We Bought Carbon Black for $2.1B!” Analysts: “Oh. Why?”

VMware: “We Bought Carbon Black for $2.1B!” Analysts: “Oh. Why?”

The deal VMware unveiled this week to buy cybersecurity firm Carbon Black trigged a heaping share of skepticism. “I'm having a hard time with the Carbon Black acquisition,”... Read more ...

GSK's Cancer Comeback Continues With Data for Multiple Myeloma Drug

GSK's Cancer Comeback Continues With Data for Multiple Myeloma Drug

An experimental GlaxoSmithKline treatment for multiple myeloma has achieved the main goal of a key study, and the drug maker plans to file for regulatory approval by the end of... Read more ...

ISAAA 2018 Report Reveals Biotech Crops Continue to Provide Solutions to...

ISAAA 2018 Report Reveals Biotech Crops Continue to Provide Solutions to Hunger, Malnutrition, and Climate Change

A total of 70 countries adopted biotech crops through cultivation and importation in 2018, the 23rd year of continuous biotech crop adoption, according to the Global Status of... Read more ...

Bio Roundup: Sarepta's Stumble, Opioid Suits, Shkreli's Legacy & More

Bio Roundup: Sarepta's Stumble, Opioid Suits, Shkreli's Legacy & More

Biotech news tends to slow down in August but the past seven days have been busy for regulatory decisions. Three drugs and two devices won FDA nods. Not all companies were as... Read more ...

Boston Tech Watch: Epstein, MIT Media Lab, Carbon Black, JRNI & More

Boston Tech Watch: Epstein, MIT Media Lab, Carbon Black, JRNI & More

A slower news week for Boston technology news, but not without its fireworks. Among them: Researchers are not taking the news well that MIT Media Lab director Joi Ito had... Read more ...

New BC Biotech Chinook Reels in $65M to Tackle Kidney Disease

New BC Biotech Chinook Reels in $65M to Tackle Kidney Disease

About 15 percent of adults in the US, or around 37 million people, are estimated to have chronic kidney disease, according to the Centers for Disease Control. There are very... Read more ...

IAmScience Henry Wan

IAmScience Henry Wan

Henry Wan | Photo by Roger Meissen, Bond LSC Every year we all tend to pay a visit to the doctor to get ahead of cold and flu season. Nothing could be worse than being in the... Read more ...

VMware Dropping $4.8B to Buy Carbon Black, Pivotal Software

VMware Dropping $4.8B to Buy Carbon Black, Pivotal Software

VMware is shelling out big bucks for two companies to fill out its technology stack: developer platform Pivotal Software for $2.7 billion and cybersecurity firm Carbon Black... Read more ...

2020 Newly Elected Members of the EMB Administrative Committee

2020 Newly Elected Members of the EMB Administrative Committee

Congratulations to the 2020 Newly Elected Members of the EMB Administrative Committee. Latin America Representative Roberto Lavarello Pontificia Universidad Católica del... Read more ...